HMedical ResearchEIN: 810935814· Ruling Year: 2016

Institute For Innovative Cancer Research Inc

Far Rockaway, New York

BHealth Score
57B

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Above Average

💰
$25K
Total Revenue
📊
$5K
Total Expenses
🏦
$63K
Net Assets
📋
$37K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+872.2%
Year-over-year change (2022 → 2023)
Net Margin
+78.9%
Revenue minus expenses as % of revenue
Working Capital Ratio
11.97
Net assets divided by total expenses
Liabilities-to-Assets
37.0%
Total liabilities as % of total assets

Filing History

6 filings on record
YearRevenueExpensesAssets
2023$25,180872%$5,306124%$100,81725%
2022$2,59089%$2,36595%$80,94287%
2021$23,06554%$48,00759%$43,39336%
2020$50,1705016900%$30,14598%$68,33541%
2019$1100%$15,208$48,309142%
2015$20,000$0$20,000

Frequently Asked Questions

What does Institute For Innovative Cancer Research Inc do?

Institute For Innovative Cancer Research Inc is a medical research nonprofit organization based in New York. It is classified under NTEE code H30 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Institute For Innovative Cancer Research Inc financially healthy?

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Institute For Innovative Cancer Research Inc.

How much revenue does Institute For Innovative Cancer Research Inc generate?

Revenue data for Institute For Innovative Cancer Research Inc is sourced from IRS filings. Detailed financial breakdowns may be available on the organization's Form 990.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in New York.